Coumaphos
Brand names: Negasunt · Active ingredient: Coumaphos
⚠ Boxed warning (FDA's strongest warning)
For external use only on animals. Do not apply directly to areas such as waterers, feed troughs, or mangers. Do not contaminate water, feed, troughs, feed handling equipment, or milk or meat handling equipment.
Use with caution in very young, weak, or debilitated animals.
Overuse may increase the risk of adverse events. In the case of overdose, treat with atropine sulfate or 2-PAM as soon as possible.
Coumaphos dosage
Apply topically to sufficiently cover the open wound. Application every 2 to 3 days may be needed for larger superficial or deep wounds. Apply until granulation tissue has formed and evidence of healing is apparent.
Warnings & precautions
Do not take this medicine if: Sulfonamides are contraindicated in animals that are hypersensitive to them and in animals with severe renal or hepatic impairment.
Withdrawal Periods and Residue Warnings
Treated animals must not be slaughtered for human consumption within 28 days of the last treatment.
A milk discard time has not been established for this product; do not use in animals producing milk for human consumption.
A withdrawal period has not been established for this product in pre-ruminating calves; treated calves and calves born to treated cows must not be processed for veal.
Not for use in humans. Keep out of reach of children.
WARNING: May be fatal if swallowed. May be fatal if inhaled. Harmful if absorbed through skin. Causes moderate eye irritation. Do not breathe dust. Avoid contact with eyes, skin, or clothing.
To avoid overexposure, each individual person cannot treat more than 3 large wounds (>2 inches diameter) a day or more than 30 small superficial wounds (≤2 inches diameter) a day (or an equivalent thereof) with Negasunt Powder or any other coumaphos-containing product.
Wear all required personal protective equipment (PPE) when handling and applying this product. Only protected handlers may be in the area during application. Do not apply this product in a way that will contact workers or other persons, either directly or through drift. Do not apply in a confined, non-ventilated area. Provide thorough ventilation.
Respirator fit testing, medical qualification, and training
Using a program that conforms to OSHA's requirements , employers must verify that any handler who uses a respirator is:
•fit-tested and fit-checked,
•trained, and
•examined by a qualified medical practitioner to ensure physical ability to safely wear the style of respirator to be worn. …
Coumaphos side effects
Clinical signs in veterinary species associated with organophosphate and carbamate toxicity include frequent urination and defecation, muscle twitching, and watering eyes, followed by salivation, diarrhea, vomiting, and muscle weakness. This can proceed to anorexia, miosis or mydriasis, dyspnea, and bradycardia or tachycardia, and can also include more rapid involuntary muscle twitching and scattered fasciculations, followed by severe weakness and paralysis.
About this medicine
Negasunt Powder (coumaphos, propoxur, and sulfanilamide topical powder) is a blue fine powder. Each gram of Negasunt Powder contains 30 mg coumaphos, 20 mg propoxur, and 50 mg sulfanilamide.
Source: FDA-approved label via DailyMed (U.S. National Library of Medicine), label set ID 1e688687-7c0d-449d-8367-163eafe724f3. Read the full official label on DailyMed.